Diabetic neuropathy was the subject of a dedicated plenary session at the congress of the Francophone Diabetes Society. This already prevalent issue is becoming more prevalent and remains inadequately addressed. Phenotyping patients is essential, and the use of neurofilament for this purpose is insufficient. Electromyography (EMG), too, can be misleading, said Agnès Hartemann, MD, PhD, head of the diabetology department at Pitié-Salpêtrière Hospital in Paris, France. "The number of people affect...